Library - Scientific articles and publications about the drug Mexidol®.

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

Влияние нейропротекторов на уровень BDNF, фактора некроза опухолей альфа и маркеров апоптоза при остром нарушении мозгового кровообращения

Алексей Владимирович Щулькин, Иван Владимирович Черных, Юлия Владимировна Абаленихина, Мария Валерьевна Гацанога, Дарья Леонидовна Кочеткова, Николай Анатольевич Кружалов, Евгения Владимировна Крестинина, Елена Николаевна Якушева

FGBOU in the Ryazan State Medical University named after Academician I.P. Pavlova "of the Ministry of Health of Russia, Ryazan, Russia

Place of publication:

Журнал неврологии и психиатрии им. С.С. Корсакова 2026, т. 126, №2, с. 123–129

Межлекарственные взаимодействия при применении препарата Мексидол у пациентов с ишемическим инсультом: анализ данных рандомизированных клинических исследований

Евгения Валерьевна Ших, Николай Анатольевич Шамалов, Станислав Николаевич Янишевский, Иван Александрович Щукин

ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России» (Сеченовский Университет), Москва, Россия;

FSBI "Federal Center for Brain and Neurotechnology" of the Federal Medical and Biological Agency of Russia, Moscow, Russia;

ФГБУ «Национальный медицинский исследовательский центр имени В.А. Алмазова» Минздрава России, Санкт-Петербург, Россия;

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Place of publication:

Журнал неврологии и психиатрии им. С.С. Корсакова 2026, т. 126, №3, с. 141–154

Оценка нейропротекторной активности Мексидола на модели геморрагического инсульта

Алексей Владимирович Щулькин, Иван Владимирович Черных, Сергей Константинович Правкин, Юлия Владимировна Абаленихина

FGBOU in the Ryazan State Medical University named after Academician I.P. Pavlova "of the Ministry of Health of Russia, Ryazan, Russia

Place of publication:

Журнал неврологии и психиатрии им. С.С. Корсакова 2026, т. 126, №3, ч. 2, с. 40–45

Современные возможности лечения сосудистых нейрокогнитивных нарушений с позиций доказательной медицины

Владимир Владимирович Захаров, Павел Андреевич Черноусов

ФГАОУ ВО «Первый Московский медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия

Place of publication:

Журнал неврологии и психиатрии им. С.С. Корсакова 2026, т. 126, №4, ч. 2, с. 76–83

Церебропротективные возможности препарата Мексидол у пациентов с артериальной гипертензией

Софья Александровна Дрешина, Станислав Николаевич Янишевский

ФГБУ «Национальный медицинский исследовательский центр им. В.А. Алмазова» Минздрава России, Санкт-Петербург, Россия

Журнал неврологии и психиатрии им. С.С. Корсакова 2026, т. 126, №4, с. 113–118

Brain aging and mechanisms of geroprotection

E.I. CHUKANOVA, A.S. CHUKANOVA

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Place of publication:
NEW THERAPEUTIC JOURNAL "NON NOCERE" / NOVEMBER 2025

Brain aging: molecular targets for geroprotection and prevention strategies

E.I. CHUKANOVA, A.S. CHUKANOVA

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Place of publication:
S.S. Korsakov Journal of Neurology and Psychiatry 2025, Vol. 125, No. 11, pp. 132–139
https://doi.org/10.17116/jnevro2025125111132

Improving the quality of life and the possibility of pathogenetic therapy in adult patients with cerebral palsy

E.A. ANTIPENKO, A.V. SHULYNDIN

Federal State Budgetary Educational Institution of Higher Education "Privolzhsky Research Medical University" of the Ministry of Health of the Russian Federation, Nizhny Novgorod, Russia

Place of publication:
S.S. Korsakov Journal of Neurology and Psychiatry 2025, Vol. 125, No. 10, pp. 75–84
https://doi.org/10.17116/jnevro202512510175

Cognitive dysfunction in children with nervous system diseases: modern approaches to diagnosis and treatment

S.A. NEMKOVA

Federal State Autonomous Educational Institution of Higher Education "N.I. Pirogov Russian National Research Medical University" of the Ministry of Health of the Russian Federation,
Moscow, Russia

Place of publication:
S.S. Korsakov Journal of Neurology and Psychiatry 2025, Vol. 125, No. 10, Issue 2, pp. 69–79
https://doi.org/10.17116/jnevro202512510269

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)

Registered on ClinicalTrials

N.A. SHAMALOV¹, A.I. FEDIN², G.S. RAKHIMBAYEVA³, E.S. NURGUZHAEV⁴, D.R. KHASANOVA⁵, E.Yu. SOLOVIOVA², E.V. MELNIKOVA⁶, S.N. YANISHEVSKY⁷, V.V. MASHIN⁸, N.V. PIZOVA⁹, I.E. Poverennova¹⁰, S.E. CHUPRINA¹¹, A.S. AGAFINA¹², L.V. ROSHKOVSKA¹³

¹Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency of the Russian Federation, Moscow, Russia;
²Pirogov Russian National Research Medical University, Moscow, Russia;
³Tashkent Medical Academy, Tashkent, Uzbekistan;
⁴Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan;
⁵Kazan State Medical University, Kazan, Russia;
⁶Leningrad Regional Center for Medical Rehabilitation, Kommunar, Russia;
⁷Almazov National Medical Research Center, Saint Petersburg, Russia;
⁸Ulyanovsk State University, Ulyanovsk, Russia;
⁹Yaroslavl State Medical University, Yaroslavl, Russia.
^10.Samara Regional Clinical Hospital named after V.D. Seredavin, Samara, Russia;
^11.Voronezh Regional Clinical Hospital No. 1, Voronezh, Russia;
^12.St. Petersburg City Hospital No. 40, St. Petersburg, Russia;
^13.St. Petersburg Alexandrovskaya Hospital, St. Petersburg, Russia

Place of publication:
S.S. Korsakov Journal of Neurology and Psychiatry 2025, Vol. 125, No. 8, Issue 2, pp. 40–53
https://doi.org/10.17116/jnevro202512508240

What you need to know about cognitive impairment

S.R. Shakirzyanova

Place of publication:
NEW THERAPEUTIC JOURNAL "NON NOCERE" SEPTEMBER 2025

Study of drug interactions between Mexidol and thrombolytic drugs

A.V. SHCHULKIN, I.V. CHERNYKH, Yu.V. ABALENIKHINA, M.V. GATSANOGA, M.M. GRADINAR,
P.D. ANANYEVA, E.N. YAKUSHEVA

FGBOU in the Ryazan State Medical University named after Acad. I.P. Pavlova "of the Ministry of Health of Russia, Ryazan, Russia

Place of publication:
S.S. Korsakov Journal of Neurology and Psychiatry 2025, Vol. 125, No. 9, pp. 139–144
https://doi.org/10.17116/jnevro2025125091139

Potential of antioxidant neuroretinoprotection in the treatment of primary open-angle glaucoma

E.A. EGOROV¹, A.V. KUROEDOV¹, ², N.A. GAVRILOVA³, A.E. YAVORSKY⁴, E.A. GORNOSTAYEVA⁵

¹Pirogov Russian National Medical Research University, Moscow, Russia;
²Mandryka Central Military Clinical Hospital,
³Russian University of Medicine, Moscow, Russia;
⁴V.P. Vykhodtsev Clinical Ophthalmological Hospital, Omsk, Russia;
⁵Zrenie Diagnostic Center, Saint Petersburg, Russia

Place of publication:
Bulletin of Ophthalmology 2025, Vol. 141, No. 4, pp. 49–59
https://doi.org/10.17116/oftalma202514104149

Attention Deficit Hyperactivity Disorder - Clinical Manifestations from Child to Adult

Authors:
L. S. Chutko, Professor, Doctor of Medical Sciences, Head of the Laboratory for Correction of Mental Development and Adaptation, Head of the Center for Behavioral Neurology at the N.P. Bekhtereva Institute of the Human Brain of the Russian Academy of Sciences, Professor at the Department of Family Medicine at the Faculty of Preparatory and Continuing Professional Education at the Saint Petersburg State Pediatric Medical University of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia

E. A. Yakovenko, Ph.D., researcher at the Institute of the Human Brain named after. N.P. Bekhtereva Russian Academy of Sciences, St. Petersburg, Russia

S. Yu. Surushkina, neurologist, PhD, research fellow at the N.P. Bekhtereva Institute of the Human Brain of the Russian Academy of Sciences, St. Petersburg, Russia

The main mechanisms of development of cognitive impairment

A.N. BOGOLEPOVA

Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
(Pirogov University), Moscow, Russia;
Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency of Russia, Moscow, Russia

Known and new ideas about the mechanism of action and spectrum of effects of Mexidol

1Federal Research Center for Original and Promising Biomedical and Pharmaceutical
Technologies, Moscow, Russia;
2Volga Region Research Medical University of the Ministry of Health of the Russian Federation, Nizhny Novgorod, Russia

1 2 3 … 14 »